The Top Line

Available every Friday morning, The Top Line podcast will recap the biggest news and why it matters—from mergers and marketing to drug R&D and device development.

Stylized 3D rendering of a DNA double helix structure set against a purple and pink background with molecular particles floa
Podcast

How Boehringer Ingelheim is buttressing its US business

In this episode of “The Top Line,” we dive into Boehringer Ingelheim’s latest regulatory wins, two key launches, and its U.S. commercialization push.
Drug Pricing

A whirlwind week for pharma

Oct 3, 2025 9:00am
Rebuilding trust in pharma in the age of misinformation

Rebuilding pharma’s credibility in the age of misinformation

Sep 19, 2025 9:47am
Inside the commercial growing pains of hemophilia gene therapies

Inside the commercial growing pains of hemophilia gene therapies

Sep 12, 2025 10:00am
Womens Health The Top Line

A rare kind of leadership, 30 years in the making

Sep 5, 2025 8:56am
Drug Pricing

Big Pharma bounces back in Q2

Aug 22, 2025 9:09am